Search Results 3501-3510 of 26420 for oral
Subject has taken any oral, injectable, or intravenous (IV) glucocorticoids within 8 weeks from time of visit 1, or plans to take any oral, injectable, or IV ...
About this study. This study will evaluate the efficacy of merimepodib (MMPD) administered orally every eight hours (q8h) for 10 days in adult patients with ...
The purpose of this study is to determine the safety and tolerability of orally administered NS-018 in patients with Primary Myelofibrosis (PMF), Post- ...
... orally twice daily (BID), or critozinib, 250 mg orally BID. Patients ... Patients randomized to GDC-0199+R will be given GDC-0199 daily (oral, target ...
Oral warfarin group medications or history of blood clotting disorders. People who have taken Bevacizumab less than 30 days prior to study muscle biopsy ...
... oral anticoagulant 21. Comorbidities limiting life expectancy to less than one year 22. Subject is currently hospitalized for definite or suspected COVID-19
... oral corticosteroids within the previous 12 months. History of idiopathic ... Treatment with therapeutic oral or IV antibiotics within 2 weeks prior to initiation ...
... (oral, intravaginal, or transdermal);; Progestogen-only hormonal contraception associated with inhibition of ovulation (oral, injectable, implantable); ...
difficile infection (CDI) after a primary episode and have completed at least two rounds of standard-of-care oral antibiotic therapy or have had at least ...
Learn about the advanced diagnostic and therapeutic procedures for people with lung (pulmonary) or chest (thoracic) disease.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.